Subscribe to Updates in Healthcare

RSS By Email

RSS By RSS

Add to Google Reader or Homepage

Subscribe in Bloglines


The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.Learn more about GLG's Compliance Framework


This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

Study Group: Dermatologists (EU)(?)

Council Members in this Study Group: 202

This study group may include physicians, care providers, and researchers specializing in internal medicine, cardiology, oncology, dermatology, emergency medicine, family medicine, neurology, obstetrics-gynecology, psychiatry, radiology, nursing, optometry, genetics, and mental health. It may also include experts knowledgeable on diagnostic labs, disease management, medical devices, long term care, surgery centers, health management, pharma, and biotechnology, among others.

Request a survey with this Study Group







GLG NewsSMAnalyses by this Study Group's Leading Experts(?)

Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.
In Maps of Cancer, the Analysis is the Problem | 09-17-2008
Author: GLG Expert Contributor

1. New developments in genetic sequencing and mapping technology now allow large-scale mapping of cancer genomes.2. The tools to interpret these data lag behind the technical possibilities.3. However, new targets for intervention may eventually be identified. 

One treatment more in the antipsoriatic topicals armamentarium | 01-16-2008
Author: GLG Expert Contributor

Of course, a new member among the antipsoriatic topical treatments could be helpful. The hypercalcemia risk is not a matter in general and could be a problem when the Vitamin D derivatives are used for more than 30% of body surface area. This situation is rare and may beneficiate from a systemic...

Promising Humira, surprinsing ABT-874 | 01-09-2008
Author: GLG Expert Contributor

By launching Humira in psoriasis indication in US and Europe, Abbott will become one of the leaders for biologic molecules. It seems that this an entirely human monoclonal antibody will improve the therapeutic options for this disease and allow the patients to get their treatment at home, improving...

Analysis of CRx-191 in Psoriasis - Comments | 11-12-2007
Author: GLG Expert Contributor

The combination of a topical steroid with an antidepressant seems to be intriguing. Antidepressant have shown some anti-pruritic activity in atopic dermatitis. The major disadvantage of the current investigational drug is the sue with occlussive dressings. That makes it impossible to use the drug for...

Sculptra: proceed with caution | 07-19-2007
Author: GLG Expert Contributor

I was trained on the use of New-fill in London about 5 years ago. My impression then was of a rather complicated to use product, compared to the existing fillers in the market like Hyaluronic Acid.

View All GLG News by members of this Study Group

Most Common Company Types:

  • Academic Medical Center/Hospital or Clinic
  • Office Based Private Practice or Clinic
  • Non-Academic Community Hospital or Clinic
  • Government/Military Hospital or Clinic
  • Academic Institution*

Most Common Job Types:

  • Physician - Attending Physician
  • Physician - Division Head
  • Owner
  • Physician - Department Chair
  • Physician - Director
  • Director
  • Research Scientist

GLG's 750+ Clients Include:

40 of the leading 50
global mutual funds
15 of the leading 20
global banks
8 of the leading 10
private equity firms
90%+ client subscription renewal rate

Analytics


Generated at 2008-11-21T05:45:43.110